You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1 Mutation

Showing 1 - 25 of 6,944
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA1/2 Flu Vaccine

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 16, 2022

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • (no location specified)
    Aug 10, 2022

    Breast Cancer BRCA1 Carriers: a Pilot Study

    Withdrawn
    • BRCA1 Mutation
    • +2 more
    • Mifepristone 200 MG
    • Prophylactic mastectomy
    • Carmel, Indiana
    • +1 more
    Dec 13, 2022

    Women With BRCA1 Germline Deleterious Mutation Trial in France (Blood sampling)

    Completed
    • Women With BRCA1 Germline Deleterious Mutation
    • Blood sampling
    • Lyon, France
    • +3 more
    Jan 18, 2022

    Searching for Novel Germline Mutations in Lobular Breast Cancer

    Recruiting
    • Lobular Breast Carcinoma
    • +3 more
    • Illumina panel
    • Milan, Italy
      European Institute of Oncology
    Sep 12, 2022

    Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • +7 more
    • (no location specified)
    Aug 1, 2022

    BRCA1 Mutation, BRCA2 Mutation Trial in New York, Durham, Houston (Family Letter (Standard of Care), Educational Video, Mailed

    Recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Family Letter (Standard of Care)
    • +3 more
    • New York, New York
    • +2 more
    Aug 12, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Registry of Subjects at Risk of Pancreatic Cancer

    Recruiting
    • Familial Pancreatic Cancer
    • +6 more
    • MRCP
    • Endoultrasonography
    • Rozzano, Milan, Italy
    • +3 more
    Jan 12, 2023

    TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • +2 more
    • (no location specified)
    Jan 12, 2022

    Nipple-sparing Mastectomy, Prophylactic Mastectomy, Breast Cancer Trial in Taoyuan (da Vinci SP? Single-port System)

    Recruiting
    • Nipple-sparing Mastectomy
    • +4 more
    • da Vinci SPⓇ Single-port System
    • Taoyuan, Taiwan
      Chang Gung Memeorial Hospital, Linkou Medical Center
    Jul 29, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    Dietary Modification, BRCA1 Mutation, BRCA2 Mutation Trial in Milano (Dietary intervention)

    Completed
    • Dietary Modification
    • +3 more
    • Dietary intervention
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Sep 27, 2021

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

    Recruiting
    • Prostate Cancer
    • +2 more
    • MRI pelvis or CT imaging
    • +2 more
    • London, Sutton, Surrey, United Kingdom
      Cancer Genetics Unit, Royal Marsden Hospital
    Mar 30, 2022

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

    Completed
    • Epithelial Ovarian Cancer
    • +6 more
    • Evaluation of homologous recombination deficiency score
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    BRCA and NACT in TNBC Patients

    Completed
    • Triple-Negative Breast Cancer
    • BRCA1/2 genetic testing
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Feb 20, 2023

    PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

    Not yet recruiting
    • BRCA Mutation
    • +2 more
    • Germinal BRCA
    • (no location specified)
    Mar 3, 2023

    Gynecologic Cancer, Breast Cancer, BRCA1 Mutation Trial in New York (Web-based family health history tool)

    Active, not recruiting
    • Gynecologic Cancer
    • +3 more
    • Web-based family health history tool
    • New York, New York
      Weill Cornell Medicine
    Feb 23, 2022